RR

(redirected from Relapsing-remitting)
Also found in: Medical.
AcronymDefinition
RRRelative Risk (medical/statistical)
RRRailroad
RRRoad Runner
RRResource Record
RRRange Rover (Land Rover)
RRRoraima (Brazil)
RRRisk Ratio
RRRolls-Royce
RRRound Robin
RRRoad Rules (MTV show)
RRRoyal Rangers
RRRoyal Rangers (Christian boy's group sponsored by the Assemblies of God)
RRRules and Regulations
RRRight Rear
RRRachael Ray (TV talkshow)
RRRapture Ready
RRReading Recovery
RRRoyal Rumble (World Wrestling Entertainment, Inc.)
RRRonald Reagan
RRResponse Rate
RRRussian Roulette
RRRanch Road (Texas)
RRRate Ratio
RRRussian River (California)
RRRace Ready (motorcycles)
RRRate of Return
RRRandy Rhoads (guitarist in Ozzy Osbourne)
RRRiesgo Relativo (Spanish: relative risk)
RRRacing Replica (Desmosedici Ducati bike)
RRRight, Right
RRRational Recovery (recovery program)
RRRoy Rogers
RRRural Route
RRRugrats
RRRace Relations
RRRuff Ryders (band)
RRReroute
RRRidge Racer (video game)
RRRed Rooster
RRReel-to-Reel
RRRun Rate (cricket)
RRRock Ridge (Linux CD-Rom File System)
RRRolling Rock (beer)
RRWeb Reasoning and Rule Systems (conference)
RRRelapsing-Remitting (Multiple Sclerosis)
RRRescue Rangers (cartoon)
RRRumble Roses (game)
RRRecovery Room
RRRefractoriness
RRReturn Result
RRRespiration Rate
RRRadio Relay
RRRegierungsrat (Austria, Europe)
RRRest Room
RRResource Room
RRRichie Rich
RRRed Rocket
RRRepetition Rate
RRRemove & Replace
RRRelative Rate
RRRegistered Representative
RRRest and Relaxation
RRRickRoll
RRRibonucleotide Reductase
RRRadio Regulations (ITU)
RRRadio Resource
RRResistance Retribution (video game)
RRRespiratory Rates
RRRural Road
RRResponse and Recovery
RRRoute Reflector
RRRadio Rumantsch (Romansh Radio, Switzerland)
RRRashtriya Rifles
RRRocky Raccoon (Beatles song)
RRReady Reserve
RRRandom Ramblings
RRRetired Reserve
RRRanger Rick
RRRecoilless Rifle
RRReserve Ratio (finance)
RRReceive Ready
RRRequirements Review
RRRecovery Repair
RRRemediation and Redevelopment (Wisconsin Department of Natural Resources)
RRReadiness Review
RRReady Room (gaming, Natural Selection)
RRRemote Registry
RRRoom to Read
RRReceiving Report
RRRelay Rack
RRRepair Request
RRRiva Rocci
RRReregistered
RRRing Return
RRRecall Rate
RRRetro-Rocket
RRRagged Right (printing and publishing)
RRRadio Regulatory
RRRain Rate (precipitation measurement)
RRRevelation Records (record label)
RRRear-Engine Rear-Wheel-Drive
RRReverse Repurchase
RRRestart Round (gaming)
RRRoaring Rapids (amusement park ride)
RRRedridge Mountains (gaming, World of Warcraft)
RRReference Receiver
RRReduced-Reference
RRRank Regression
RRRed Ribbon Army (gaming)
RRReporting Responsibility
RRReceive Ring
RRRosenthal & Rosenthal
RRRoad Robber
RRRadio Rack
RRRoad Rover
RRReview and Release
RRRoute Relay
RRRocket Rods
RRRipper Roo (Crash Bandicoot character)
RRReverse Request
RRRelative Relief
RRRendezvous Radar
RRRejection Report
RRRiparian Reserves
RRRestart Recovery
RRR-to-R Interval (the cycle between two consecutive R-waves)
RRReverse Relay
RRRight Recursive (grammar parsing)
RRRadiant Recovery
RRRegister to Register Instruction
RRReasoning and Rules
RRReuse Ratio
RRRuck Rover (Australian football position)
RRRoper Resources (oceanic equipment manufacturer; Canada)
RRreattack recommendation (US DoD)
RRReference Reflector (Agilent)
RRRiparian Reaches
RRRobot Resources
RRRepetition Redundancy
RRRefracted - Refracted
RRRegional Reinforcement
RRRecharge Ratio
RRRivetRider (EC-130 special operations aircraft)
RRResidential Rough (HVAC)
RRRandom Randumb (Slapstick & prank comedy web show)
RRRaze Resources (forum)
RRRefugees de Rwanda
RRRestoral/Reconfiguration
RRRenegotiation Regulation
RRRotary Rectifier
RRRoaming Replicator
RRRebel Resistance (gaming)
References in periodicals archive ?
Pharmacokinetics of Daclizumab High-Yield Process (DAC HYP) with Repeated Administration of the Clinical Subcutaneous Regimen in Subjects With Relapsing-Remitting Multiple Sclerosis; Tran, J.
Dr Ben Turner, consultant neurologist and honorary senior lecturer at Barts and The London NHS Trust, said: "As the UK chief investigator for Tecfidera's Define study, having seen the obvious benefits of Tecfidera in MS patients I'm delighted that people with relapsing-remitting MS will now have access to this new treatment.
Clinical and Magnetic Resonance Imaging Predictors of Long-Term Outcomes in Patients with Relapsing-Remitting Multiple Sclerosis: Additional Analyses (poster P05.
The aim of the Betaferon Efficacy Yielding Outcomes of a New Dose (BEYOND) trial, funded by Bayer HealthCare Pharmaceuticals, was to compare the efficacy, safety, and tolerability of 250 micro/g or 500 micro/g interferon beta-1b with Glatiramer acetate for treating relapsing-remitting multiple sclerosis.
A group of 891 patients was assessed over time to evaluate the rate of conversion from relapsing-remitting MS to secondary progressive MS (steady decline that develops after a period of relapsing-remitting symptoms).
Women with relapsing-remitting MS interested in the possibility of participating should consult with their physicians or contact one of the medical centers listed on our Web site.
This phase III trial is following 500 people with relapsing-remitting MS taking either both drugs or Copaxone and an inactive placebo.
The purpose of this study was to examine perceived cognitive impairment in secondary progressive and relapsing-remitting MS and to examine the relationship between level of disability, age, number of years with MS and self-reported cognitive symptoms.
People with relapsing-remitting MS are now being enrolled in a multicenter clinical trial designed to test the safety and effectiveness of combining Avonex (interferon beta-1a) with other immune-suppressing drugs.
neurologists and managed care organization (MCO) pharmacy directors agree that a drug's effect on sustained disability progression is one of the efficacy attributes that most influences their decisions regarding prescribing and formulary status determinations, respectively, in relapsing-remitting multiple sclerosis.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that the Russian Federal Service on Surveillance in Healthcare and Social Development has become the first government agency to grant marketing approval to Cladribine Tablets for the treatment of relapsing-remitting multiple sclerosis (MS).